1v1 Institutional Counterparty Comparison
Cytoswap vs OnEquity: Regulation, 6D Ratings & Safety Audit
Deterministic head-to-head benchmarking of Cytoswap (Cytoswap) and OnEquity (OnEquity) across primary regulatory filings, statutory Tier-1 authorisations, 6-Dimension compliance scores, execution software, and warning exposure.
Coverage: Institutions licensed in offshore financial centres
OnEquity outranks Cytoswap by +4.7 pts in composite 6D scoring (6.7 vs 2.0)
On supervisory breadth, Cytoswap holds 0 active regulated licence(s) (0 Tier-1) out of 0 total filings and 0 warning count(s), whereas OnEquity holds 3 active regulated licence(s) (0 Tier-1) out of 3 total filings and 0 warning count(s). Allocators should inspect the individual licence numbers and contracting legal entities below before onboarding.
6-Dimension Quantitative Scorecard Comparison
Head-to-head breakdown across all 6 proprietary evaluation dimensions (0.0–10.0 scale).
| Evaluation Dimension | Methodology Weight | Cytoswap | OnEquity | Score Delta | Dimension Leader |
|---|---|---|---|---|---|
| Overall Composite 6D Score | 100% Composite | 2.0 | 6.7 | +4.7 | OnEquity |
| Regulatory & Licensing Integrity (riskScore) | 30% Weight | 2.0 | 5.0 | +3.0 | OnEquity |
| Execution & Software Infrastructure (industryScore) | 20% Weight | 1.0 | 4.0 | +3.0 | OnEquity |
| User Reputation & Complaint Telemetry (userScore) | 20% Weight | 0.0 | 0.0 | 0.0 | Statistical Tie |
| Institutional Brand Longevity (brandScore) | 15% Weight | 2.0 | 6.5 | +4.5 | OnEquity |
| Global Market Influence & Footprint (influenceScore) | 15% Weight | 2.0 | 5.0 | +3.0 | OnEquity |
Visual Architecture Benchmark: Cytoswap vs OnEquity
Vector comparison exhibit generated from live supervisory snapshot metrics.
Regulatory Standing, Entity & Platform Comparison
Structural comparison of supervisory authorisations, domicile, execution terminals, and risk telemetry.
| Audit Attribute | Cytoswap | OnEquity |
|---|---|---|
| Primary Legal Name | Cytoswap | OnEquity |
| Source Risk Classification | Risk level not supplied | Risk level not supplied |
| Active Regulated / Total Filings | 0 regulated / 0 total (0 Tier-1) | 3 regulated / 3 total (0 Tier-1) |
| Recorded Certificate Numbers | None on file | |
| Registered Domicile / Address | International | CT House, Office 6C, Providence, Mahe, Seychelles |
| Offered Asset Classes & Services | Trading | Forex currencies, commodities, global indices, stock CFDs, spot precious metals and cryptocurrency CFDs |
| Execution Software & Terminals | Proprietary / Web Platform | Proprietary / Web Platform |
| Supported Client Languages | English | English |
| Warning / Exposure Count | 0 recorded warning(s) | 0 recorded warning(s) |
Frequently Asked Questions: Cytoswap vs OnEquity
Deterministic counterparty comparison answers derived from supervisory records.
Which institution has stronger regulatory oversight: Cytoswap or OnEquity?
OnEquity holds more active regulated filings (3 vs 0). Specifically, Cytoswap maintains 0 total recorded filing(s) (none on file) with 0 warning flag(s), whereas OnEquity maintains 3 recorded filing(s) (SVG FSA, Financial Services Authority Seychelles, FSCA) with 0 warning flag(s). Always confirm the specific subsidiary onboarding your account on the official regulator register.
How do the 6D quantitative compliance scores compare between Cytoswap and OnEquity?
In Sovereign Tax Atlas's 6-Dimension scoring matrix (0.0–10.0 scale), Cytoswap records an Overall Score of 2.0 (Risk & Licensing: 2.0, Brand: 2.0, Market Influence: 2.0, User Reputation: 0.0, Execution & Software: 1.0), compared with OnEquity at 6.7 Overall (Risk & Licensing: 5.0, Brand: 6.5, Market Influence: 5.0, User Reputation: 0.0, Execution & Software: 4.0).
How do Cytoswap and OnEquity differ in trading platforms and asset classes?
Cytoswap lists Trading with execution software [proprietary/web execution], while OnEquity lists Forex currencies, commodities, global indices, stock CFDs, spot precious metals and cryptocurrency CFDs with execution software [proprietary/web execution]. Counterparties should verify FIX/API connectivity, server routing topology, and negative balance protection per entity.
Which counterparty carries lower regulatory warning and complaint exposure: Cytoswap or OnEquity?
Cytoswap carries a "Risk level not supplied" classification with 0 warning/exposure count(s) and 0 user comment(s), while OnEquity carries a "Risk level not supplied" classification with 0 warning/exposure count(s) and 0 user comment(s).
Structured against supervisory register snapshots and public regulatory filings. Verify your contracting legal entity and current authorisation status directly on the issuing regulator’s official register before transacting.
